| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Esophageal Neoplasms | D004938 | 20 associated lipids |
| Bone Resorption | D001862 | 7 associated lipids |
| Arthritis | D001168 | 41 associated lipids |
| Surgical Wound Infection | D013530 | 7 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Hypotension | D007022 | 41 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
erythromycin
erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.
Cross Reference
Introduction
To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with erythromycin?
erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (35)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (2)
- Others (29)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with erythromycin
PubChem Associated disorders and diseases
What pathways are associated with erythromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with erythromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with erythromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with erythromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with erythromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (19)
- J. Antimicrob. Chemother. (10)
- Drug Metab. Dispos. (5)
- Others (29)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with erythromycin?
Mouse Model
Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).
Knock-out
Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with erythromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Konturek JW and Domschke W | [Gastroparesis--physiopathology, diagnosis and the latest therapy]. | 1998 | Dtsch. Med. Wochenschr. | pmid:9556697 |
| Lilley LL and Guanci R | Drug interaction triggers weakness. | 1998 | Am J Nurs | pmid:9556673 |
| Schwarz MI | A man with dyspnea, productive cough, and chest radiograph showing hyperinflation and a diffuse nodular pattern. | 1998 | Chest | pmid:9554657 |
| Mortensen JE et al. | In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida. | 1998 | Diagn. Microbiol. Infect. Dis. | pmid:9554176 |
| Mück W et al. | Influence of erythromycin pre- and co-treatment on single-dose pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. | 1998 | Eur. J. Clin. Pharmacol. | pmid:9551706 |
| Chakrabarti MK et al. | Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine. | 1998 Mar-Apr | Chemotherapy | pmid:9551241 |
| Sachdeo RC et al. | Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy. | 1998 | J Clin Pharmacol | pmid:9549651 |
| Tanaka E and Breimer DD | In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease. | 1997 | J Clin Pharm Ther | pmid:9548204 |
| Bertho G et al. | Transferred nuclear Overhauser effect study of macrolide-ribosome interactions: correlation between antibiotic activities and bound conformations. | 1998 | Bioorg. Med. Chem. | pmid:9547944 |
| Li YX et al. | Sensitive determination of erythromycin in human plasma by LC-MS/MS. | 1998 | J Pharm Biomed Anal | pmid:9547699 |
| Fitzgerald NB et al. | Sonication-dependent electroporation of the erythromycin-producing bacterium Saccharopolyspora erythraea. | 1998 | Appl. Environ. Microbiol. | pmid:9546194 |
| Thomas AR et al. | Prolongation of the QT interval related to cisapride-diltiazem interaction. | 1998 Mar-Apr | Pharmacotherapy | pmid:9545159 |
| Norcia LJ et al. | In vitro microbiological characterization of novel macrolide CP-163,505 for animal health specific use. | 1998 | J. Antibiot. | pmid:9544934 |
| Williamson KM et al. | Effects of erythromycin or rifampin on losartan pharmacokinetics in healthy volunteers. | 1998 | Clin. Pharmacol. Ther. | pmid:9542475 |
| Jacobsen JR et al. | Spontaneous priming of a downstream module in 6-deoxyerythronolide B synthase leads to polyketide biosynthesis. | 1998 | Biochemistry | pmid:9538011 |
| Lyon AJ et al. | Randomised trial of erythromycin on the development of chronic lung disease in preterm infants. | 1998 | Arch. Dis. Child. Fetal Neonatal Ed. | pmid:9536833 |
| Choi MG et al. | Dose-related effects of N-demethyl-N-isopropyl-8, 9-anhydroerythromycin A 6,9-hemiacetal on gastric emptying of solids in healthy human volunteers. | 1998 | J. Pharmacol. Exp. Ther. | pmid:9535992 |
| Stout JE et al. | Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells. | 1998 | J. Antimicrob. Chemother. | pmid:9533475 |
| Nasher MA and Hay RJ | Synergy of antibiotics against Streptomyces somaliensis isolates in vitro. | 1998 | J. Antimicrob. Chemother. | pmid:9533473 |
| Doucet-Populaire F et al. | Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis. | 1998 | J. Antimicrob. Chemother. | pmid:9533459 |
| Molinari JA | Multifactorial aspects of legionellosis. | 1997 | Compend Contin Educ Dent | pmid:9533308 |
| Salmon SA et al. | Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark. | 1998 | J. Dairy Sci. | pmid:9532511 |
| Constantine PA | Antibiotic therapy and serum digoxin toxicity. | 1998 | Am Fam Physician | pmid:9531908 |
| den Hollander JG et al. | Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo. | 1998 | Antimicrob. Agents Chemother. | pmid:9527789 |
| Seppälä H et al. | A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. | 1998 | Antimicrob. Agents Chemother. | pmid:9527769 |
| Ponomareva TR and Smolianskaia AZ | [Prevalence of markers characteristic for penicillinase plasmids in clinical strains of straphylococci]. | 1976 | Antibiotiki | pmid:952503 |
| Roberts GJ et al. | Bacteremia of dental origin and antimicrobial sensitivity following oral surgical procedures in children. | 1998 Jan-Feb | Pediatr Dent | pmid:9524970 |
| Janicka G et al. | [Resistance to antibiotics of Streptococcus pneumoniae strains]. | 1997 | Pol. Merkur. Lekarski | pmid:9523479 |
| Liu PC et al. | Susceptibility of different isolates of Vibrio harveyi to antibiotics. | 1997 | Microbios | pmid:9523424 |
| Lester GD et al. | Effect of erythromycin lactobionate on myoelectric activity of ileum, cecum, and right ventral colon, and cecal emptying of radiolabeled markers in clinically normal ponies. | 1998 | Am. J. Vet. Res. | pmid:9522953 |
| Esposito S et al. | Clinical comparison of cefaclor twice daily versus amoxicillin-clavulanate or erythromycin three times daily in the treatment of patients with streptococcal pharyngitis. | 1998 Jan-Feb | Clin Ther | pmid:9522105 |
| Service RF | Hijacking a cell's chemical paths to make new antibiotics. | 1997 | Science | pmid:9518361 |
| Lalloo AK and Kanfer I | Determination of erythromycin and related substances by capillary electrophoresis. | 1997 | J. Chromatogr. B Biomed. Sci. Appl. | pmid:9518168 |
| Lalloo AK et al. | Development of a capillary electrophoretic method for the separation of the macrolide antibiotics, erythromycin, josamycin and oleandomycin. | 1997 | J. Chromatogr. B Biomed. Sci. Appl. | pmid:9518167 |
| Pankuch GA et al. | Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. | 1998 | Antimicrob. Agents Chemother. | pmid:9517943 |
| Sato K et al. | Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice. | 1998 | Am. J. Respir. Crit. Care Med. | pmid:9517602 |
| Lu G et al. | Effect of motilin and erythromycin on calcium-activated potassium channels in rabbit colonic myocytes. | 1998 | Gastroenterology | pmid:9516395 |
| Wynn RL | Serious erythromycin interactions caused by inhibition of drug metabolism in the liver. | 1996 Nov-Dec | Gen Dent | pmid:9515389 |
| Noguchi N and Katayama J | Expression in Pseudomonas aeruginosa of an erythromycin-resistance determinant that encodes the mphA gene for macrolide 2'-phosphotransferase I from Escherichia coli. | 1998 | Biol. Pharm. Bull. | pmid:9514620 |
| Perez-Trallero E et al. | Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. | 1998 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:9512178 |
| Jorgensen JH and McElmeel ML | Activity of quinupristin/dalfopristin and its components against Haemophilus influenzae. | 1997 | J. Antimicrob. Chemother. | pmid:9511067 |
| Williams JD et al. | Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. | 1997 | J. Antimicrob. Chemother. | pmid:9511061 |
| Manninen R et al. | Reliability of disc diffusion susceptibility testing of Streptococcus pneumoniae and adjustment of laboratory-specific breakpoints. Finnish Study Group for Antimicrobial Resistance. | 1998 | J. Antimicrob. Chemother. | pmid:9511033 |
| Hay PE | Therapy of bacterial vaginosis. | 1998 | J. Antimicrob. Chemother. | pmid:9511031 |
| Chen JD et al. | Effects of octreotide and erythromycin on gastric myoelectrical and motor activities in patients with gastroparesis. | 1998 | Dig. Dis. Sci. | pmid:9508540 |
| Tsiaoussis I et al. | Gallbladder fasting volume is reduced and gallbladder postprandial emptying is enhanced by intravenous erythromycin. | 1998 | Dig. Dis. Sci. | pmid:9508522 |
| Rivera P et al. | [Collagenous colitis: presentation of 12 cases]. | 1997 | Gastroenterol Hepatol | pmid:9508483 |
| Kamoun A et al. | [Pneumococcal infections: penicillin resistance and therapeutic implications]. | 1995 | Tunis Med | pmid:9506153 |
| Wong SL et al. | The effect of erythromycin on the CYP3A component of sertindole clearance in healthy volunteers. | 1997 | J Clin Pharmacol | pmid:9505999 |
| Woodward A and Sillin LF | Oral erythromycin improves gastrointestinal motility and transit after subtotal but not total gastrectomy for cancer. | 1998 | Br J Surg | pmid:9501836 |